Metraipolis › archive › dc_e55cf088176f

Adverse Reactions of First-Line Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma Treatment: A Descriptive Analysis From WHO-VigiAccess — Europe PMC PMID:40980823

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40980823
DOI
10.1155/ijh/5548453
License (as archived)
solo-consultazione
Archived
2026-11-09T23:40:26.818Z
SHA-256 of the archived text
99c0af47e0c914db5da729fc4e5d2569c0b97b023a3cd60b81a009eb004f0621
Stable URL of this page
https://metraipolis.com/documento/dc_e55cf088176f

How to cite

Adverse Reactions of First-Line Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma Treatment: A Descriptive Analysis From WHO-VigiAccess — Europe PMC PMID:40980823 — Europe PMC (en), https://europepmc.org/article/MED/40980823 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e55cf088176f (Metraipolis archive dc_e55cf088176f, sha256 99c0af47e0c914db5da729fc4e5d2569c0b97b023a3cd60b81a009eb004f0621)
BibTeX
@misc{dce55cf088176f,
  title = {Adverse Reactions of First-Line Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma Treatment: A Descriptive Analysis From WHO-VigiAccess — Europe PMC PMID:40980823},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40980823},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e55cf088176f; sha256 99c0af47e0c914db5da729fc4e5d2569c0b97b023a3cd60b81a009eb004f0621},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40980823. Agents can read the archived copy with the MCP tool read_document.